newsfilter
← Latest News
GlobeNewswire·

Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic Review

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial...